In particular, the NFkB-activating cytokines (LTA, IL-1B) are expected to synergize with IL-17A and IL-17F for the induction of many typical “IL-17 pathway” products in keratinocytes that initiate “feed forward” inflammation and help to maintain pathogenic gene expression profiles in psoriasis. Here, IL17F is linked to psoriasis.